A previous study on HeLa cells shows that cancer therapy using p53 siRNA specifically triggers apoptotic mechanisms [19, 20, 21], and increases the efficiency of other therapeutic agents by increasing the sensitivity of cancer cells to apoptosis [20]. The gene discussed is TP53; the disease is cancer.